Viewing Study NCT06393335

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:31 PM
Ignite Modification Date: 2026-07-12 @ 4:16 AM
Study NCT ID: NCT06393335
Status: RECRUITING
Last Update Posted: 2024-05-01
First Post: 2024-04-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
Sponsor: The Children's Hospital of Zhejiang University School of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
None Non-hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Meta10-19 View
None CAR-T Cells Therapy View
None CD19-positive B cell Hematological Malignancies View